KRAS and medical procedure: Although sequencing certain oncogenes such as KRAS in cell free DNA has proven useful in pancreatic44 and colorectal cancer45, detection methods remain poor and although improving, sequencing costs are still relatively expensive for widespread clinical roll-out.